piwik-script

Deutsch Intern

    Coinfection: More than the sum of its parts

    11/18/2020

    Infections with two pathogens pose a serious threat in the clinics. Researchers from Würzburg and Jena have developed a technique that provides new insights into this process and can be used as an early warning system.

    Von Monozyten abgeleitete dendritische Zellen nach einer Infektion mit dem Zytomegalievirus (grün) und dem Schimmelpilz Aspergillus fumigatus (rot). Fluoreszenzmikroskopie, Maßstab 100 µm.
    Monocyte-derived dendritic cells after an infection with Aspergillus fumigatus (red) and the human cytomegalovirus (green). (Image: AG Löffler)

    Organ and stem cell transplants are proven and frequently used methods in everyday modern clinical practice. However, even when performed regularly in specialized centers, some patients still experience a number of serious complications afterwards. Among other things, infections with fungi and viruses can jeopardize therapeutic success. For example, coinfection with cytomegalovirus, which belongs to the family of Herpes viruses, and the fungus Aspergillus fumigatus can be critical. This combination of pathogens poses a serious medical threat in organ and stem cell transplantation.

    When viruses and fungi join forces

    A team of scientists from several German research institutions and clinics has now developed a new method to examine these two pathogens, their interaction with each other and with the human cells infected by them. The central result: coinfection with the two pathogens is more "than the sum of its parts". Viruses and fungi interact synergistically in the human organism, where they trigger certain genes that only become active when infected with both pathogens simultaneously.

    The study involved scientists from the Julius Maximilian University of Würzburg (JMU), the Würzburg University Hospital (UKW), the Leibniz Institute for Natural Product Research and Infection Biology in Jena and the Helmholtz Institute for RNA-based Infection Research (HIRI) in Würzburg, a site of the Braunschweig Helmholtz Centre for Infection Research (HZI). The results have now been published in the journal Cell Reports.

    New insights thanks to a novel technology

    "For our study, we have developed a method called Triple RNA-seq," explains Alexander Westermann. He is junior professor at the Chair of Molecular Infection Biology I at JMU, as well as group leader at the HIRI. Together with Jürgen Löffler from UKW and Sascha Schäuble he is one of the senior authors of the study. The scientists have advanced an established method that has been an integral part of infection research for years: dual RNA-seq.

    The term “RNA-seq” is short for RNA-sequencing: This technique enables the simultaneous and precise determination of the activities of thousands of genes at the RNA level in a high-throughput process, thus enabling the identification and better understanding of the changes occurring in the course of diseases. The development of dual RNA sequencing has made it possible to document not only the gene activity of a pathogen, but also the reaction of the host cell affected by it. This has enabled scientists to trace complex causal chains over the course of an infection.

    Research on immune cells

    Now, Triple RNA sequencing dissects the gene expression of three players and their interplay in infection processes. "Up to now, science has in many cases not known why an infection with a certain pathogen can make the affected person more susceptible to an infection with a second pathogen," explains Jürgen Löffler, molecular biologist at the Medical Clinic II of the UKW. In such cases, dual RNA-seq was insufficient to provide the desired answers.

    In their study, the researchers used the triple RNA-seq method they developed to investigate what happens when certain cells of the immune system (known as monocyte-derived dendritic cells) are infected with both Aspergillus fumigatus and the human cytomegalovirus.

    They were able to prove that the two pathogens influence each other, whilst also simultaneously affecting the immune cell in a different way than one pathogen alone otherwise would. For example, the cytomegalovirus weakened the fungal-mediated activation of pro-inflammatory signals, while Aspergillus affects viral clearance - the time it takes for the virus to become undetectable in tests.

    Hope for a biomarker

    At the same time, the team has identified specific genes in immune cells whose expression profiles differ significantly during an infection with both pathogens, compared to a single infection. These genes could thus serve as biomarkers for the timely identification of a co-infection after transplantation.

    The scientists now hope that the triple RNA-seq technology will also help to better understand other cases of common infections, such as viruses and bacteria, and to prevent their potentially serious consequences. "Promising models for understanding how an infection makes the host more susceptible to another pathogen include certain strains of Salmonella and the human immunodeficiency virus (HIV), streptococci and influenza virus, or Chlamydia and human herpes virus," says Westermann. As a next step, Westermann plans to use the triple RNA-seq technique to investigate infections in which two different types of bacteria jointly influence the course of the disease.

    Original publication

    Triple RNA-seq reveals synergy in a human virus-fungus co-infection model. Bastian Seelbinder*, Julia Wallstabe*, Lothar Marischen*, Esther Weiss, Sebastian Wurster, Lukas Page, Claudia Löffler, Lydia Bussemer, Anna-Lena Schmitt, Thomas Wolf, Jörg Linde, Luka Cicin-Sain, Jennifer Becker, Ulrich Kalinke, Jörg Vogel, Gianni Panagiotou, Hermann Einsele, Alexander J. Westermann*, Sascha Schäuble*, Juergen Loeffler*. Cell Reports, DOI: 10.1016/j.celrep.2020.108389

    Contact

    Prof. Dr. Alexander J. Westermann, Lehrstuhl für Molekulare Infektionsbiologie I, T: +49 931 31-83781, alexander.westermann@uni-wuerzburg.de

    Prof. Dr. Jürgen Löffler, Medizinische Klinik II, T: +49 931 20136412, loeffler_j@ukw.de

    By Gunnar Bartsch

    Back